Miromatrix Medical Inc. (Nasdaq: MIRO), relating to its proposed sale to United Therapeutics Corp. Under the terms of the agreement, MIRO shareholders will receive $3.25 and potentially an additional payment of $1.75 in cash per share they own.
Miromatrix Medical Inc. (Nasdaq: MIRO), relating to its proposed sale to United Therapeutics Corp. Under the terms of the agreement, MIRO shareholders will receive $3.25 and potentially an additional payment of $1.75 in cash per share they own.